Research and Markets: Specialty Pharma: Guide to Success at the New Frontier Available Now
Posted on: Thursday, 7 June 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c59117) has announced the addition of "Specialty Pharma: Guide to Success at the New Frontier" to their offering.
Recently catapulted into the pharmaceutical industry limelight, Specialty Pharma may well be the solution to many of Big Pharma's current woes. Its success driven largely by astute manipulation of the business and market issues that currently plague Big Pharma, Specialty Pharma has shown the potential to capture and firmly command market spaces once dominated by Big Pharma.
Get the Answers You Need to Shape Your Strategy
The emergence of Specialty Pharma as a market force occurred as Big Pharma and Mid Pharma began to consolidate. What strategies will Specialty Pharma pursue as it continues to capitalize on Big Pharma's looming market problems?
Patents have become a trapdoor for both Big Pharma and Mid Pharma alike; once patents expire, these companies find themselves hanging in a market abyss. What methods are Specialty Pharma using to sidestep such patent expiry pitfalls? What specific markets or patient cohorts are receiving attention from Specialty Pharma?
Value-for-money is the mantra of today's knowledgeable and organized health care customers -- a challenge for Specialty Pharma, which has received condemnation over its pricing of orphan drugs. How can Specialty Pharma best present its pricing practices to an increasingly informed and skeptical consumer audience?
Scope
Market drivers: business factors and issues that are driving the transformation of the pharma market.
Market overview: market conditions that contributed to the emergence and subsequent growth of Specialty Pharma.
Success and uncertainty: how Specialty Pharma's success has altered its market space, and how these companies need to respond to the changing marketplace.
Specialty Pharma business models: 11 business models, with examples of companies that utilize them.
Challenges: threats to the continued growth of the Specialty Pharma sector.
Market outlook: opportunities and strategies for Specialty Pharma companies to succeed in today's changing pharma business environment.
Companies Mentioned:
Abbott
Ache
Actavis
Alcon
Allergan
Almirall Prodespharma
Altana Pharma
Anthrogenesis
AstraZeneca
Barr Pharmaceuticals
Basilea Pharmaceutica
BioMarin Pharmaceutical
Cambridge Laboratories
Carter-Wallace (now MedPointe Pharmaceuticals)
Celgene
Cell Therapeutics
Cephalon
Chiesi Farmaceutici
Connetics
Dako
Dermal Laboratories
Eli Lilly and Company
Endo Pharmaceuticals
Ferring Pharmaceuticals
Forest Laboratories
Galderma
Galen Holdings
Gilead Sciences
GlaxoSmithKline
Gruenenthal
Hermal Kurt Herrmann
Hoffmann-La Roche
Hospira
ICOS
Idun Pharmaceuticals
King Pharmaceuticals
Laboratorios Bago
Laboratorios Esteve
Lemmon Pharmacal
Ligand Pharmaceuticals
Link Pharmaceuticals
H. Lundbeck
Mayne Pharma
Medac
Medimmune
Menarini Group
MSD-Chibret
Myogen
New River Pharmaceuticals
Novartis
Noven Pharmaceuticals
Nycomed
Orphan Europe
Pain Therapeutics
For more information, visit http://www.researchandmarkets.com/reports/c59117.
Source: Business Wire
Related Articles
- Whirlpool Corporation Named One of the Greenest Big Companies in America
- Research and Markets: North America Pharmaceuticals Sectors: A Company and Industry Analysis (July 2008) - in 2007, Total Drugs Spending in Canada Totalled C$27 Billion (US$26.75 Billion)
- U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals and Dr. Reddy's Laboratories
- Astralux Environmental Solutions Announces the Appointment of Fred T. Martin As Director of Sales and Marketing of the Company's Power Systems Group
- Research and Markets: Amerisourcebergen Drug Company and Pharmerica Are Some of the Lines of Business Mentioned Inside the 'Amerisourcebergen Business Intelligence Report'
- Pharmaceutical Operating Companies of Johnson & Johnson Continue Patient Assistance for Eligible Medicare Beneficiaries
- EH&E Launches Affordable Web-Based Compliance Support to Help Companies With Laboratories Reduce Risk and Improve Safety
- Forbes Names Landstar to Its 'Platinum 400 List of America's Best Big Companies' for the Seventh Consecutive Year and 'One of the Best Managed Companies in America'
- Plus Three Announces Partnership With PetitionThem; Strategic Marketing and Technology Company for Political and Non-Profit Organizations Expands Reach to Activists
- OpSource Selected to Present 'SaaS Challenges & Answers' at SLAM 2005: Sales, Licensing, Alliances & Marketing for Software Companies
 |
 |
User Comments (0)
RSS Feeds